- Influence of food intake on the absorption and effect of glipizide in diabetics and in healthy subjects - (https://pubmed.ncbi.nlm.nih.gov/7002565/)
- Gliclazide-induced acute hepatitis - (https://pubmed.ncbi.nlm.nih.gov/10656221/#:)
- Effects of gliclazide on platelet aggregation and the plasminogen activator inhibitor type 1 level in patients with type 2 diabetes mellitus - (https://pubmed.ncbi.nlm.nih.gov/20070990/#:)
- Normal pregnancy and healthy child after continued exposure to gliclazide and ramipril during pregnancy - (https://pubmed.ncbi.nlm.nih.gov/19109210/)
- Sulfonylureas - (https://www.ncbi.nlm.nih.gov/books/NBK513225/)
Gliclazide (Vidzid-XR (30mg)) is an oral hypoglycemic (anti-diabetic drug), prescribed for type 2 diabetes.It stimulates the pancreas, which helps in more insulin secretion.
The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak with a healthcare professional.
Vidzid-XR (30mg) - Vidakem Lifesciences Pvt. Ltd.
Vidzid-XR (30mg) Tablet
Generic : Gliclazide
₹
40
30mg
10
Substitute/Alternative Medication to Vidzid-XR (30mg)
Aliza (80 mg) | Apdeb (80 mg) | Aviglic 80mg Tablet | Azukon (80 mg) | Azukon MR (30 mg) | Betazide (80 mg) | Bizid (80 mg) | Cgcron (30 mg) | Cgcron (60 mg) | Cgcron (80 mg)
When is Vidzid-XR (30mg) prescribed?
It is prescribed for -
⇨
Diabetes
